Internal Medicine, Cardiovascular Disease · Sellersville, PA
NPI
1275533218
Since 2005
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
3 Life Mark Dr
Sellersville, PA, 18960
Phone (215) 257-1127
Groups this clinician bills Medicare through
Medicare paid, 2024
$193K
5,853 services
Medicare patients, 2024
1,607
Average age 77
Drug cost, 2024
$1.5M
8,581 prescriptions
Company payments, 2025
$970
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mitchell M Greenspan was code 93010 (electrocardiogram), 1,623 times for 926 patients. In total Mitchell M Greenspan billed 5,853 services in 54 codes, and Medicare paid $193K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 93010 Electrocardiogram | Facility | 1,623 | 926 | $6.37 | $10K |
| 93000 Electrocardiogram | Office | 756 | 455 | $11.10 | $8,392 |
| 93306 Echocardiography (TTE/TEE) | Facility | 429 | 416 | $52.33 | $22K |
| 93793 Care Management/Coordination | Office | 420 | 33 | $8.25 | $3,466 |
| 99214 Office E&M - Established | Office | 401 | 311 | $95.03 | $38K |
| 99232 Hospital E&M - Subsequent | Facility | 298 | 151 | $61.65 | $18K |
| 93296 External Electrocardiographic Monitoring | Office | 269 | 94 | $16.55 | $4,451 |
| 93294 External Electrocardiographic Monitoring | Office | 214 | 78 | $22.15 | $4,741 |
| 85610 Clinical Chemistry | Office | 176 | 14 | $4.20 | $739 |
| 99215 Office E&M - Established | Office | 172 | 138 | $143.08 | $25K |
| 99213 Office E&M - Established | Office | 164 | 150 | $70.35 | $12K |
| 99231 Hospital E&M - Subsequent | Facility | 115 | 71 | $39.12 | $4,499 |
| 99222 Hospital E&M - Initial | Facility | 104 | 91 | $99.87 | $10K |
| 93298 External Electrocardiographic Monitoring | Office | 93 | 16 | $78.93 | $7,340 |
| 78452 Myocardial Perfusion Scan | Facility | 74 | 74 | $59.24 | $4,383 |
By year: 2022 $174K for 4,948 services; 2023 $153K for 4,154 services; 2024 $193K for 5,853 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 176 | 14 | $4.20 | $739 |
Medicare prescription drug claims, 2024
In 2024, the drug Mitchell M Greenspan prescribed most often to Medicare patients was Atorvastatin Calcium, with 528 prescriptions and refills. In total Mitchell M Greenspan wrote 8,581 Medicare prescriptions that cost $1.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 528 | 1,481 | 155 | $8,356 |
| Metoprolol Succinate Generic | 470 | 1,227 | 132 | $7,409 |
| Eliquis Apixaban | 441 | 709 | 86 | $403K |
| Clopidogrel Clopidogrel Bisulfate | 375 | 1,026 | 115 | $5,828 |
| Xarelto Rivaroxaban | 367 | 658 | 73 | $345K |
| Pravastatin Sodium Generic | 336 | 920 | 91 | $7,072 |
| Losartan Potassium Generic | 295 | 790 | 79 | $4,871 |
| Spironolactone Generic | 271 | 601 | 66 | $1,639 |
| Farxiga Dapagliflozin Propanediol | 221 | 323 | 44 | $177K |
| Furosemide Generic | 213 | 504 | 64 | $1,228 |
| Metoprolol Tartrate Generic | 209 | 536 | 55 | $1,251 |
| Ezetimibe Generic | 207 | 529 | 57 | $4,359 |
| Jardiance Empagliflozin | 199 | 317 | 39 | $182K |
| Amiodarone Hcl Generic | 196 | 486 | 55 | $3,741 |
| Amlodipine Besylate Generic | 184 | 531 | 56 | $1,540 |
Brand drugs: - claims; generic drugs: 6,989 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mitchell M Greenspan $970 ($970 in general payments such as food, travel and fees) from 15 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $170.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $170 |
| Novartis Pharmaceuticals Corporation NVS | 10 | $159 |
| Boston Scientific Corporation BSX | 10 | $143 |
| Novo Nordisk Inc NVO | 4 | $90.53 |
| Pfizer Inc. PFE | 3 | $71.08 |
| Merck Sharp & Dohme LLC MRK | 3 | $69.19 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $57.16 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $35.66 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $33.96 |
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $32.1 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.